We are live on ! Find out more
FMT

First Mercantile Trust Portfolio holdings

AUM $755M
1-Year Est. Return 28.15%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+28.15%
3 Year Est. Return
+51.22%
5 Year Est. Return
+128.6%
10 Year Est. Return
–
AUM
$847M
AUM Growth
-$26.5M
Cap. Flow
-$75.1M
Cap. Flow %
-8.87%
Top 10 Hldgs %
45.25%
Holding
916
New
76
Increased
162
Reduced
591
Closed
61

Top Buys

Rank Stock Value
1
VIGI icon
Vanguard International Dividend Appreciation ETF
VIGI
+$12.9M
2
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$2.05M
3
FREL icon
Fidelity MSCI Real Estate Index ETF
FREL
+$843K
4
TRGP icon
Targa Resources
TRGP
+$614K
5
A icon
Agilent Technologies
A
+$567K

Top Sells

Rank Stock Value
1
EFAV icon
iShares MSCI EAFE Min Vol Factor ETF
EFAV
+$13.5M
2
SCHX icon
Schwab US Large- Cap ETF
SCHX
+$11.1M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$7.05M
4
VGIT icon
Vanguard Intermediate-Term Treasury ETF
VGIT
+$4.49M
5
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 9.14%
2 Consumer Discretionary 6.54%
3 Healthcare 6.31%
4 Financials 5.93%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
726
Dyne Therapeutics
DYN
$4.19B
$85K 0.01%
4,017
-531
-12% -$9.98K
PTCT icon
727
PTC Therapeutics
PTCT
$6.38B
$85K 0.01%
2,005
-215
-10% -$9.21K
RETA
728
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$85K 0.01%
598
-62
-9% -$7K
KYMR icon
729
Kymera Therapeutics
KYMR
$9.16B
$84K 0.01%
1,728
+555
+47% +$24.1K
ACRS icon
730
Aclaris Therapeutics
ACRS
$761M
$83K 0.01%
+4,712
New +$107K
AIN icon
731
Albany International
AIN
$2.16B
$83K 0.01%
926
-200
-18% -$17.5K
ALXO icon
732
ALX Oncology
ALXO
$277M
$83K 0.01%
1,521
+117
+8% +$7K
ARVN icon
733
Arvinas
ARVN
$535M
$83K 0.01%
1,080
-109
-9% -$7.57K
HAE icon
734
Haemonetics
HAE
$3.66B
$83K 0.01%
+1,241
New +$87.8K
LXP icon
735
LXP Industrial Trust
LXP
$3.54B
$83K 0.01%
1,388
-45
-3% -$2.74K
YMAB
736
DELISTED
Y-mAbs Therapeutics
YMAB
$83K 0.01%
2,445
-304
-11% -$9.76K
HRTX icon
737
Heron Therapeutics
HRTX
$88.2M
$82K 0.01%
5,300
-582
-10% -$9.26K
LPG icon
738
Dorian LPG
LPG
$1.86B
$82K 0.01%
5,810
+55
+1% +$769
MDGL icon
739
Madrigal Pharmaceuticals
MDGL
$12.9B
$82K 0.01%
842
-55
-6% -$6.51K
THR
740
DELISTED
Thermon Group Holdings
THR
$82K 0.01%
4,788
-1,122
-19% -$20.9K
NTLA icon
741
Intellia Therapeutics
NTLA
$1.52B
$81K 0.01%
+500
New +$38.9K
SITM icon
742
SiTime
SITM
$15.6B
$80K 0.01%
+634
New +$64.8K
PRSU
743
Pursuit Attractions and Hospitality Inc
PRSU
$1.45B
$80K 0.01%
+1,600
New +$70.7K
ARNA
744
DELISTED
Arena Pharmaceuticals Inc
ARNA
$79K 0.01%
1,164
-97
-8% -$6.32K
MRSN
745
DELISTED
Mersana Therapeutics
MRSN
$78K 0.01%
231
-14
-6% -$5.3K
FISV
746
Fiserv Inc
FISV
$27.8B
$77K 0.01%
720
– –
KRTX
747
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$77K 0.01%
672
+311
+86% +$36.4K
GNTX icon
748
Gentex
GNTX
$4.83B
$76K 0.01%
+2,300
New +$79.8K
MRCY icon
749
Mercury Systems
MRCY
$6.18B
$76K 0.01%
1,149
-60
-5% -$4.15K
MRTX
750
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$75K 0.01%
464
-247
-35% -$39.7K
28 29
30
31 32

Similar funds

LBD
Landsberg Bennett & Dubbaneh Punta Gorda, Florida $785M AUM 22.85% 1-Year Est. Return
SIM
Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return
OAM
Optimal Asset Management Los Altos, California $800M AUM 28.13% 1-Year Est. Return
KFM
KG Funds Management New York $855M AUM 22.34% 1-Year Est. Return
BCA
Berman Capital Advisors Atlanta, Georgia $636M AUM 30.04% 1-Year Est. Return
GIA
Granite Investment Advisors Concord, New Hampshire $618M AUM 31.33% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
BJ
Brouwer & Janachowski Mill Valley, California $574M AUM 24.29% 1-Year Est. Return

First Mercantile Trust's Q2 2021 Portfolio in Review

As of Q2 2021, First Mercantile Trust held 916 positions worth $847M, down 3% from $873M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

First Mercantile Trust withdrew a net $75.1M in Q2 2021, closing 61 positions and reducing 591 holdings. Its most notable exit was Canadian National Railway, an estimated $1.59M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, First Mercantile Trust opened a new position in Vanguard International Dividend Appreciation ETF worth $13.1M.

  • First Mercantile Trust's largest Q2 2021 buy was Vanguard International Dividend Appreciation ETF: 149,385 shares worth $13.1M.
  • First Mercantile Trust added most to Schwab US Dividend Equity ETF in Q2 2021, an estimated $2.05M increase.
  • First Mercantile Trust's biggest Q2 2021 reduction was iShares MSCI EAFE Min Vol Factor ETF, cutting an estimated $13.5M.
  • First Mercantile Trust fully exited Canadian National Railway in Q2 2021, selling an estimated $1.59M.
  • First Mercantile Trust's ten largest holdings make up 45% of its $847M portfolio in Q2 2021.
  • First Mercantile Trust opened 76 new positions and closed 61 in Q2 2021.
  • First Mercantile Trust's portfolio value fell 3% quarter-over-quarter to $847M.

Based on First Mercantile Trust's 13F filing for Q2 2021, filed 10 Aug 2021.